Literature DB >> 2021584

Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease.

S J Charles1, P A Meyer, P G Watson.   

Abstract

The ocular and systemic features of 10 patients whose Wegener's granulomatosis presented with corneoscleral inflammatory disease are described. Marginal corneal infiltrates were seen in all patients with anterior scleritis and were a valuable sign of disease activity. Nine out of 10 patients had symptoms of systemic vasculitis on presentation; seven had renal impairment; three had chest x-ray abnormalities. Autoantibodies against neutrophil cytoplasmic determinants (ANCA) were present in all cases. In seven patients the scleritis responded well to pulsed immunosuppressive therapy followed by long term oral steroids and cyclophosphamide. Oral steroid therapy alone failed to control severe disease. Corneoscleral disease was not a cause of visual loss. It is important to realise that inflammatory corneoscleral disease may be the presenting feature of a severe systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021584      PMCID: PMC1042320          DOI: 10.1136/bjo.75.4.201

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Wegener's granulomatosis: pathology and review of the literature.

Authors:  G C GODMAN; J CHURG
Journal:  AMA Arch Pathol       Date:  1954-12

2.  'Pulsed' immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease.

Authors:  P A Meyer; P G Watson; W Franks; P Dubord
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

3.  Premalignant and malignant skin tumours in immunosuppressed patients.

Authors:  V Marshall
Journal:  Transplantation       Date:  1974-03       Impact factor: 4.939

4.  Sudden death following high-dose intravenous methylprednisolone.

Authors:  J F Thompson; D H Chalmers; R F Wood; S R Kirkham; P J Morris
Journal:  Transplantation       Date:  1983-11       Impact factor: 4.939

5.  Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.

Authors:  C R Hind; C G Winearls; C M Lockwood; A J Rees; M B Pepys
Journal:  Clin Nephrol       Date:  1984-06       Impact factor: 0.975

6.  Ocular changes in limited forms of Wegener's granulomatosis.

Authors:  D J Spalton; E M Graham; N G Page; M D Sanders
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

7.  Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener's granulomatosis.

Authors:  H L Harrison; M A Linshaw; C B Lindsley; F E Cuppage
Journal:  JAMA       Date:  1980-10-03       Impact factor: 56.272

Review 8.  Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases.

Authors:  R T McCluskey; R Fienberg
Journal:  Hum Pathol       Date:  1983-04       Impact factor: 3.466

9.  Fluorescein angiography in the differential diagnosis of sclerokeratitis.

Authors:  P Watson; S Booth-Mason
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  6 in total

1.  Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement.

Authors:  M Blum; K Andrassy; D Adler; M Hartmann; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

2.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

3.  Ocular disease in patients with ANCA-positive vasculitis.

Authors:  Angela S Watkins; John H Kempen; Dongseok Choi; Teresa L Liesegang; S S Pujari; Craig Newcomb; Robert B Nussenblatt; James T Rosenbaum; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Eric B Suhler; Justine R Smith
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

4.  Granulomatosis with polyangiitis presenting as a choroidal tumor.

Authors:  Taro Masuda; Yasumori Izumi; Hayato Takeshita; Chieko Kawahara; Yoshika Tsuji; Hirokazu Kurohama; Nozomi Iwanaga; Miwako Inamoto; Keiichi Kase; Masahiro Ito; Atsushi Kawakami; Kiyosi Migita
Journal:  Case Rep Rheumatol       Date:  2015-04-08

5.  Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab.

Authors:  Yuya Fujita; Shoichi Fukui; Yushiro Endo; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Masataka Umeda; Ayako Nishino; Tomohiro Koga; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Ryotaro Ueki; Masafumi Uematsu; Kaori Ishida; Kuniko Abe; Atsushi Kawakami
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

Review 6.  Systemic immunosuppressive therapies for uveitis in developing countries.

Authors:  Hitesh Agrawal; Hien Doan; Brandon Pham; Amit Khosla; Manohar Babu; Peter McCluskey; Quan Dong Nguyen; Virender Sangwan; Subhakar Reddy; Sujata Sawhney; Mudit Tyagi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.